Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model
- PMID: 29460345
- DOI: 10.1111/myc.12754
Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model
Abstract
The incidence of invasive fungal infections (IFIs) caused by uncommon Candida species with diverse virulence and susceptibility profiles has increased in recent years. Due to scarce clinical and experimental data on the pathogenicity of Candida auris, the aim of this study was to evaluate and compare the virulence of two rare clinically relevant species, C. auris and Candida haemulonii with Candida glabrata and Candida albicans in an immunocompetent murine model of disseminated infection. Immunocompetent ICR female mice were infected with three inoculum sizes (1 × 105 , 1 × 106 and 1 × 107 CFU/mouse) of two C. auris strains and one isolate of C. haemulonii, C. glabrata and C. albicans. Tissue burden on days 5 and 10 postchallenge and mortality rate were used as virulence markers. A high virulence was found for C. albicans, followed by C. auris, C. glabrata and C. haemulonii, respectively. Candida albicans showed high virulence with a medium survival time of 9.5 days for mice infected with 1 × 107 CFU/mouse. For inocula at 1 × 106 and 1 × 107 CFU/mouse, there were significant differences in fungal burden at day 10 between C. albicans, C. auris and C. glabrata isolates compared with C. haemulonii (P < .0001). Overall, no significant differences between C. albicans with C. auris and C. glabrata were observed in mice infected with three different inocula (P > .05). In general, the highest fungal load of all isolates was detected in kidney followed by spleen, liver and lung tested with three different inocula on the two different experimental days. Histopathological examination revealed the abundant presence of yeast cells with pseudohyphae for C. albicans and only yeast cells for C. auris, C. glabrata and C. haemulonii, in all the kidney tissue samples. In conclusion, C. albicans is a highly virulent opportunistic fungus, as the clinical and experimental data demonstrate, and also our results demonstrate a low virulence of C. haemulonii in immunocompetent animals. Altogether, this study highlights the pathogenic potential of C. auris.
Keywords: Candida auris; disseminated candidiasis; murine model; pathogenicity; survival study; tissue burden.
© 2018 Blackwell Verlag GmbH.
Similar articles
-
Potency of gastrointestinal colonization and virulence of Candida auris in a murine endogenous candidiasis.PLoS One. 2020 Dec 2;15(12):e0243223. doi: 10.1371/journal.pone.0243223. eCollection 2020. PLoS One. 2020. PMID: 33264362 Free PMC article.
-
In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02542-17. doi: 10.1128/AAC.02542-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29378706 Free PMC article.
-
Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.Infect Immun. 2001 Aug;69(8):5046-55. doi: 10.1128/IAI.69.8.5046-5055.2001. Infect Immun. 2001. PMID: 11447185 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin.Int J Mol Sci. 2019 May 11;20(9):2345. doi: 10.3390/ijms20092345. Int J Mol Sci. 2019. PMID: 31083555 Free PMC article. Review.
Cited by
-
Liposomal amphotericin B-the future.J Antimicrob Chemother. 2022 Nov 25;77(Suppl_2):ii21-ii34. doi: 10.1093/jac/dkac353. J Antimicrob Chemother. 2022. PMID: 36426674 Free PMC article.
-
Candida auris: An emerging pathogen "incognito"?PLoS Pathog. 2019 Apr 8;15(4):e1007638. doi: 10.1371/journal.ppat.1007638. eCollection 2019 Apr. PLoS Pathog. 2019. PMID: 30958866 Free PMC article. No abstract available.
-
Caenorhabditis elegans as an Infection Model for Pathogenic Mold and Dimorphic Fungi: Applications and Challenges.Front Cell Infect Microbiol. 2021 Oct 15;11:751947. doi: 10.3389/fcimb.2021.751947. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34722339 Free PMC article. Review.
-
Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics.Gut Microbes. 2024 Jan-Dec;16(1):2328868. doi: 10.1080/19490976.2024.2328868. Epub 2024 Mar 14. Gut Microbes. 2024. PMID: 38485702 Free PMC article. Review.
-
Pathogenicity Levels of Colombian Strains of Candida auris and Brazilian Strains of Candida haemulonii Species Complex in Both Murine and Galleria mellonella Experimental Models.J Fungi (Basel). 2020 Jul 10;6(3):104. doi: 10.3390/jof6030104. J Fungi (Basel). 2020. PMID: 32664191 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources